<DOC>
	<DOCNO>NCT00744666</DOCNO>
	<brief_summary>Intravitreal triamcinolone acetonide ( IVTA ) commonly employ treatment various vitreoretinal disorder . However , approximately 23 % 50 % patient receive IVTA develop ocular hypertension drug inject eye . Similar IVTA , topically administer corticosteroid eye drop result ocular hypertension approximately 33 % population . It unknown whether identify patient develop ocular hypertension topical corticosteroid could use identify patient risk injectable IVTA . Therefore , purpose study evaluate efficacy topical prednisolone 1 % four time daily one month screen test reduce incidence severity ocular hypertension IVTA injection .</brief_summary>
	<brief_title>IntraVitreal Triamcinolone Acetonide : Preventing Raised Eye-pressure Tracking Elevations After Topical Steroids</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Patients diagnose vitreoretinal disease IVTA chosen treatment &lt; 18 year old Pregnancy Breast feed hx uveitis hx neovascularization iris anterior chamber angle hx ocular herpes simplex keratitis hx glaucoma Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Intravitreal triamcinolone acetonide</keyword>
	<keyword>Side-effects</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>Prevention</keyword>
	<keyword>Vitreoretinal disease require IVTA treatment</keyword>
</DOC>